Clark Sullivan

clark1

Cox Biosciences LLC

2019-2020

Technologies

Therapeutic

Indication

Central Nervous System Disorders

Developmental Disorders

Cox Biosciences is a phase III drug development company developing a promising therapy for improving communication in children with autism.

Newsletter Signup

Corporate Supporters

Community Service Providers